Elevated Nrf2 protein levels are observed in cancers, such as lung, head and neck, gall bladder, and pancreatic cancer [30,31], and a gain of Nrf2 function enhances cell proliferation and confers radioresistance and chemoresistance in these cancer types [1,16,32,33]. This evidence concerns the gene NFE2L2 and medical procedure.